文献速递冠心病

稳定性缺血性心脏病管理范式的演变:JACC本周综述

Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

该综述指出稳定性冠心病的传统管理基于血流限制性狭窄是心绞痛和心肌缺血主要原因的假设,但血运重建仅对左主干病变、糖尿病三支病变或射血分数降低者降低长期心脏事件。越来越多的证据表明非心外膜冠脉原因如冠脉微血管功能障碍、血管痉挛性疾病和心肌代谢异常比血流限制性狭窄更常见,需要更包容的管理范式。

要点

  • 血运重建降低长期心脏事件仅限于左主干病变、糖尿病三支病变或射血分数降低者。
  • 非心外膜冠脉原因如微血管功能障碍、血管痉挛和心肌代谢异常比血流限制性狭窄更常见。
  • 需要将心外膜CAD与血运重建的单一关联解耦,诊断方法应针对心绞痛和缺血的潜在机制。

核心结论

  • 稳定性冠心病管理需从仅关注心外膜狭窄和血运重建转向更包容的范式,涵盖微血管功能障碍、血管痉挛和心肌代谢异常等非心外膜原因。

研究设计与样本

  • JACC综述,未报告系统检索范围或样本量。

主要发现

  • 血运重建降低长期心脏事件的作用主要限于左主干病变、糖尿病三支病变或射血分数降低的患者。
  • 冠脉微血管功能障碍、血管痉挛性疾病和心肌代谢异常等非心外膜原因比血流限制性狭窄更常见。
  • 许多重要病因未被诊断性评估考虑或探查。

临床怎么用

  • 临床应超越仅评估心外膜狭窄,诊断性探查微血管功能障碍、血管痉挛和心肌代谢异常。
  • 治疗应针对心绞痛和缺血的潜在机制及诱因,而非仅基于心外膜CAD与血运重建的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Management of stable coronary artery disease (CAD) has been based on the assumption that flow-limiting atherosclerotic obstructions are the proximate cause of angina and myocardial ischemia in most patients and represent an important target for revascularization. However, the role of revascularization in reducing long-term cardiac events in these patients has been limited mainly to those with left main disease, 3-vessel disease with diabetes, or decreased ejection fraction. Mounting evidence indicates that nonepicardial coronary causes of angina and ischemia, including coronary microvascular dysfunction, vasospastic disorders, and derangements of myocardial metabolism, are more prevalent than flow-limiting stenoses, raising concerns that many important causes other than epicardial CAD are neither considered nor probed diagnostically. There is a need for a more inclusive management paradigm that uncouples the singular association between epicardial CAD and revascularization and better aligns diagnostic approaches that tailor treatment to the underlying mechanisms and precipitants of angina and ischemia in contemporary clinical practice.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Boden WE, Marzilli M, Crea F, et al. Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week. J Am Coll Cardiol. 2023. PMID: 36725179. doi:10.1016/j.jacc.2022.08.814

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。